Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ozurdex in Diabetic Macular Edema
NCT03475407Phase 4Unknown
- Sponsor
- Nune Eye Hospital
- Start
- Mar 2015
- Primary completion
- Jun 2018
- Modality
- Implantable Devices, Implantable Hydrogels, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ozurdex in diabetic macular edema (DME), sponsored by Nune Eye Hospital. Status: unknown.
02
Drugs
ozurdex
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT03475407.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03475407.